Dr. J. Patrick Whelan, a pediatric rheumatologist, warned the Food and Drug Administration (FDA) back in December that mRNA injections have the potential to cause microvascular injury to the brain, heart, liver and kidneys – and in ways that were not even assessed during safety trials.
On Dec. 8, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) released a public submission from Whelan that was a response to the agency’s request for comments regarding so-called “vaccines” for the Chinese Virus. This occurred in anticipation of a Dec. 10 meeting at which the committee was scheduled to review the Pfizer-BioNTech injection for emergency use authorization (EUA).
In his public submission, Whelan, a veteran physician with decades of experience in his field, alerted the FDA to these potential vaccine injuries, noting that the spike protein component of the jabs is a potential trigger for serious injuries.
Whelan explained that experimental mRNA technology has “the potential to cause microvascular injury (inflammation and small blood clots called microthrombi) to the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.”
No comments:
Post a Comment